Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Teva Parenteral Medicines, Inc.
FDA Inspection
•Teva Parenteral Medicines, Inc.•July 24, 2009

Teva Parenteral Medicines, Inc. – FDA Inspection, Jul 24, 2009

Record Details

This FDA Inspection record concerns Teva Parenteral Medicines, Inc., with an inspection on July 24, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Teva Parenteral Medicines, Inc.
Inspection Date
July 24, 2009
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 220bdfb4-c9ee-463f-a61e-e7f2acdfc7f4

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
603521
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

16
  1. 21 CFR 211.165(d)Acceptance criteria for sampling & testing
  2. 21 CFR 211.42(c)(10)(vi)Equipment to control conditions
  3. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  4. 21 CFR 211.192Quality control unit review of records
  5. 21 CFR 211.165(b)Microbiological testing
  6. 21 CFR 211.84(d)(6)Objectionable microbiological contamination
  7. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  8. 21 CFR 211.63Equipment Design, Size and Location
  9. 21 CFR 211.110(c)In-process materials characteristics testing
  10. 21 CFR 211.192Extent of discrepancy, failure investigations

Showing 10 of 16 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Teva Parenteral Medicines, Inc.

11
DateClassificationOfficeProject area
August 20, 2021OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 30, 2019NAICenter for Drug Evaluation and ResearchNew Drug Evaluation
January 18, 2019VAILos Angeles District OfficeGeneric Drug Evaluation
December 19, 2016NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 29, 2016VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 11 other inspections on the company page
Other documents for Teva Parenteral Medicines, Inc.
  • FDA Inspection 1149378 - 2021-08-20
  • FDA Inspection 1100853 - 2019-08-30
  • FDA Inspection 1077528 - 2019-01-18
  • FDA Inspection 997582 - 2016-12-19
  • FDA Inspection 980903 - 2016-07-29

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Teva Parenteral Medicines, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.